TRIMEBUTINE MEDISOL 50 mg/5 ml, solution for injection 5 ampoules of 5 ml
Active ingredients: Trimebutine maleate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIMEBUTINE MEDISOL 50 mg/5 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- MEDISOL
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62387842CIP73026615CIP133400930266151Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TRIMÉBUTINEsolution | 50 mg · une ampoule de 5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.